Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
NCT02536599 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2023-07-24
Summary
The aim of the study is to identify clinical and laboratory parameters, present at the time of initial evaluation that could help predict which children with cancer, fever, and neutropenia will be at risk for developing clinically documented infections and/ or complications.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2023-10-31
- Completion
- 2023-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
NCT01813721 ·Status: COMPLETED
-
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
NCT03530072 ·Status: COMPLETED
-
Registry of Febrile Neutropenia and Invasive Fungal Infections
NCT01684189 ·Status: UNKNOWN
-
Pediatric FN Definition 2012 Bern
NCT01683370 ·Status: COMPLETED
-
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
NCT02866851 ·Status: TERMINATED ·Phase: NA
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
NCT04081753 ·Status: COMPLETED ·Phase: NA
-
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854 ·Status: COMPLETED
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
NCT04557709 ·Status: WITHDRAWN
-
Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia
NCT03449693 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522 ·Status: RECRUITING
-
Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
NCT04910698 ·Status: COMPLETED
-
The Oral Cavity as a Source of Febrile Neutropenia
NCT02702583 ·Status: COMPLETED
-
Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients
NCT03823950 ·Status: UNKNOWN ·Phase: PHASE4
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
NCT00003739 ·Status: COMPLETED ·Phase: PHASE3
-
Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia
NCT02816112 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia
NCT04000711 ·Status: COMPLETED ·Phase: NA
-
Early Antibiotic Discontinuation in FUO
NCT02906254 ·Status: COMPLETED
-
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
NCT03434795 ·Status: COMPLETED
-
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
NCT03968328 ·Status: COMPLETED
-
Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
NCT02912117 ·Status: COMPLETED
-
Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia
NCT04250038 ·Status: UNKNOWN
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED